Allelic loss of the active X chromosome during bladder carcinogenesis

Arch Pathol Lab Med. 2004 Feb;128(2):187-90. doi: 10.5858/2004-128-187-ALOTAX.

Abstract

Context: Previous studies have shown that loss of the X chromosome is involved in the carcinogenesis of certain human malignancies.

Objective: To determine whether X-linked allelic losses occur during bladder tumorigenesis and whether such losses involve the active or the inactive X chromosome.

Design: We analyzed the deletion status of the X-linked human androgen receptor gene locus in 6 female patients who underwent radical cystectomies for muscle-invasive urothelial carcinoma of the urinary bladder. Four patients had coexisting urothelial carcinoma in situ. Analysis for inactivation of the X chromosome was carried out in parallel.

Results: Three cases were informative. Invasive tumor samples showed loss of heterozygosity involving the active allele at the androgen receptor locus in all 3 positive cases, whereas carcinoma in situ showed nonrandom X chromosome inactivation but not allelic deletion.

Conclusions: Our data suggest that allelic loss of the activated X chromosome is involved in bladder carcinogenesis and cancer progression.

MeSH terms

  • Carcinoma / genetics*
  • Carcinoma / pathology
  • Chromosomes, Human, X*
  • Female
  • Humans
  • Loss of Heterozygosity*
  • Receptors, Androgen / genetics
  • Urinary Bladder Neoplasms / genetics*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Receptors, Androgen